MedPath

DOBURIS

Brand Name: DOBURIS

Generic Name: Dobutamine Hydrochloiride

Expiring Soon
Registration Number

DR-XY46922

Dosage Form

Solution For Intravenous Infusion

Issuance Date

October 31, 2020

Expiry Date

October 31, 2025

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength50 mg/ mL
PackagingIn a box of 1-Type I amber ampoule x 5 mL (Box of 5's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Cardiac Stimulant (Adrenergic and dopaminergic agent)
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Dobutamine HydrochloirideActive
Monograph: dobutamine hydrochloiride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.